BPC-157
Also known as Body Protection Compound 157, PL 14736
Gastric pentadecapeptide studied for soft-tissue and gut repair.
- Category
- healing
- Route
- subq
- Documented dose
- 200–500 mcg
- Typical frequency
- Once or twice daily
- Cycle
- 6 weeks on, 4 off
- Half-life
- ~4 hours (subcutaneous, estimated)
- Common vial sizes
- 5 mg, 10 mg
- Regulatory status
- Not approved for human use; research chemical in most jurisdictions.
What it does
A stable copy of a protective peptide found naturally in stomach fluid. Its main reputation is speeding up repair in tissue that normally heals slowly, and calming inflammation where it is applied or injected. What people look into it for: • Tendon, ligament and muscle injuries that are slow to heal • Gut problems such as ulcers, leaky gut, IBD-type inflammation and NSAID damage • Joint pain and post-surgical or post-injury recovery • Better blood-vessel growth into healing tissue, which brings in oxygen and nutrients • Some reports of improved mood and nerve recovery The animal evidence is broad and consistent; controlled human trials are still limited.
Mechanism
Appears to upregulate VEGF-driven angiogenesis and growth-factor receptor expression at injury sites; modulates the nitric-oxide system.
Storage — lyophilised
Refrigerate 2-8C; stable at room temperature short term, protect from light.
Storage — reconstituted
Refrigerate 2-8C, use within ~28 days.
Reconstitution notes
Add 2 ml bacteriostatic water to a 5 mg vial for 25 mcg per insulin-syringe unit.
Commonly stacked with
- TB-500
- KPV
Commonly reported side effects
- Injection-site irritation
- Lightheadedness
- Nausea
Contraindications noted
- Active malignancy (theoretical, via angiogenesis)
- Pregnancy or breastfeeding
Research notes
Almost all evidence is preclinical rodent data; no large human trials published.
Track this properly
Work out syringe units with the free calculator, or set up a full schedule in about a minute.
Reference information only, not medical advice. See our medical disclaimer.